Abstract
The influence of tamoxifen (TAM) and medroxyprogesterone acetate (MPA) sequential administration on the estrogen receptor (ER) and progesterone receptor (PR) contents of breast cancer was studied in 68 patients with operable breast cancer. TAM was used as a primer of PR induction in order to enhance the effects of MPA. Half of the patients (n=34) were preoperatively treated with TAM (20 nig/day for 7 days) and sequentially with MPA (1200 mg/day for 17 (median) days). ER and PR of surgical specimens were assayed by enzyme immunoassay and the results were compared with those obtained from the other half of the patients (n=34), who had not received any treatment before surgery. TAM‐MPA treatment significantly lowered PR in the cytosol regardless of the menopausal status. On the other hand, TAM‐MPA treatment significantly lowered ER in the cytosol only in the postmenopausals but not in the premenopansals. These results demonstrate that reduction of ER provoked by TAM‐MPA treatment is dependent on menopausal status.
Keywords: Tamoxifen, Medroxyprogesterone, Estrogen receptor, Progesterone receptor
Full Text
The Full Text of this article is available as a PDF (322.5 KB).
REFERENCES
- 1. ) Namer , M. , Lalanne , C. and Baulieu , E. E.Increase of progesterone receptors by tamoxifen as a hormonal challenge test in breast cancer . Cancer Res. , 40 , 1750 – 1752 ( 1980. ). [PubMed] [Google Scholar]
- 2. ) Iacobelli , S. , Sica , G. , Natoli , C. and Gatti , D.Inhibitory effects of medroxyprogesterone acetate on the proliferation of human breast cancer cells . In “ Role of Medroxyprogesterone Acetate in Endocrine‐related Tumors ,” ed. Campio L. , Robustelli della Cuna G. and Tayler R. W. , Vol. 2 , pp. 1 – 6 ( 1983. ). Raven Press; , New York . [Google Scholar]
- 3. ) Tominaga , T. , Yoshida , Y. , Kitamura , M. and Kosaki , G.Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12‐dimethylbenz[α]‐ anthracene‐induced rat mammary tumors in relation to hormone receptors . Jpn. J, Cancer Res. , 76 , 1120 – 1125 ( 1985. ). [PubMed] [Google Scholar]
- 4. ) Garcia‐Giralt , E. , Jouve , M. , Palangie , T. , Bretaudeau , B. , Dorval , T. , Asselain , B. , Magdelenat , H. , Merle , S. , Zajdela , A. and Pouillart , P.Disseminated breast cancer: sequential administration of tamoxifen and medroxyprogesterone acetate. Results of a controlled trial . Rev. Endocr. Relat. Cancer , Suppl. 18 , 27 – 32 ( 1986. ). [Google Scholar]
- 5. ) Gundersen , S. , Kvinnsiand , S. and Klepp , O.Cyclic use of tamoxifen and high‐dose medroxyprogesterone acetate in advanced breast cancer . Rev. Endocr. Rel Cancer , Suppl. 18 , 37 – 41 ( 1986. ). [Google Scholar]
- 6. ) Tseng , L. and Gurpide , E.Effects of progestins on estradiol receptor levels in human endometrium . J. Clin. Endocrinol. Metab. , 41 , 402 – 404 ( 1975. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Noguchi , S. , Miyauchi , K. , Imaoka , S. , Koyama , H , and Iwanaga , T.Comparison of enzyme immunoassay with dextran‐coated charcoal method in the determination of progesterone receptor in breast cancer cytosols . Eur. J. Cancer Clin. Oncol. , 24 , 1715 – 1719 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Lowry , O. H. , Rosebrough , N. J. , Farr , A. L. and Randwall , R. J.Protein measurement with the Folinphenol reagent . J. Biol Chem. , 193 , 265 – 275 ( 1951. ). [PubMed] [Google Scholar]
- 9. ) Burton , K. H.A study of the conditions and mechanism of diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid . Biochem. J. , 62 , 315 – 323 ( 1956. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Noguchi , S. , Miyauchi , K. , Nishizawa , Y. and Koyama , H.Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time . Cancer , 61 , 1345 – 1349 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Thorpe , S. M. , Lykkesfeldt , A. E. , Vinterby , A. and Lonsdorfer , M.Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies . Cancer Res. , 46 , 4251 – 4255 ( 1986. ). [PubMed] [Google Scholar]
- 12. ) King , W. J. and Greene , G. L.Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells . Nature , 307 , 745 – 747 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Press , M. F. and Greene , G. L.Localization of progesterone receptor with monoclonal antibodies of human progestin receptor . Endocrinology , 122 , 1165 – 1175 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Horwitz , K. B. , Wei , L. L. , Sedlacek , S. M. and D'Arville , C. N.Progestin action and progesterone receptor structure in human breast cancer: a review . Recent Prog. Hormone Res. , 41 , 249 – 316 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Lundgren , S. , Kvinnsland , S. , Varhaug , J. E. and Utaaker , E.The influence of progestins on receptor levels in breast cencer metastasis . Anticancer Res. , 7 , 119 – 124 ( 1987. ). [PubMed] [Google Scholar]
- 16. ) Smyth , C. M. , Benn , D. E. and Reeve , T. S.Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies . Breast Cancer Res. Treat. , 11 , 45 – 50 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Saez , S. , Martin , P. M. and Chouvet , C. D.Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels . Cancer Res. , 38 , 3468 – 3473 ( 1978. ). [PubMed] [Google Scholar]
- 18. ) Adam , H. K.Pharmacokinetic studies with “Nolvadex” . Rev. Endocr. Relat. Cancer , Suppl. 9 , 131 – 143 ( 1981. ). [Google Scholar]